Justin Orlando Ortiz, Anna K Potter, Imaan Benmerzouga
{"title":"Novel Drug Targets for the Bradyzoite Form of <i>Toxoplasma gondii</i>.","authors":"Justin Orlando Ortiz, Anna K Potter, Imaan Benmerzouga","doi":"10.2147/RRTM.S431290","DOIUrl":null,"url":null,"abstract":"<p><p><i>Toxoplasma gondii</i> is a world-wide parasite, with an estimated prevalence of approximately 30%. Toxoplasmosis is a severe disease in the immunocompromised, but few symptoms are exhibited by patients with an intact immune system, making this parasite a worldwide burden. Currently, few drugs exist in treating acute toxoplasmosis and no drugs exist to eliminate the bradyzoite of <i>T. gondii</i>. Effective therapies against acute and chronic toxoplasmosis are urgently needed to reduce the burden of this disease. This review aims to give a summary of recent findings in the bradyzoite form of <i>Toxoplasma gondii</i> and the implication of these findings on drug development. A thorough search of PubMed and Google Scholar databases was used to identify studies within the past 10 years that illustrate targetable key elements in the differentiation and formation of the bradyzoite form of <i>T. gondii.</i></p>","PeriodicalId":21138,"journal":{"name":"Research and Reports in Tropical Medicine","volume":"16 ","pages":"25-30"},"PeriodicalIF":3.1000,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11963886/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research and Reports in Tropical Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/RRTM.S431290","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
摘要
弓形虫是一种全球性寄生虫,估计发病率约为 30%。弓形虫病对免疫力低下的人来说是一种严重的疾病,但免疫系统完好的病人却很少出现症状,因此这种寄生虫成为全世界的负担。目前,治疗急性弓形虫病的药物很少,也没有消除刚地弓形虫缓虫的药物。目前迫切需要针对急性和慢性弓形虫病的有效疗法,以减轻这种疾病的负担。这篇综述旨在概述最近在刚地弓形虫的裂殖体形式方面的发现,以及这些发现对药物开发的影响。我们对 PubMed 和 Google Scholar 数据库进行了全面搜索,以确定过去 10 年中有哪些研究说明了刚地弓形虫幼虫形态分化和形成过程中的可靶向关键因素。
Novel Drug Targets for the Bradyzoite Form of Toxoplasma gondii.
Toxoplasma gondii is a world-wide parasite, with an estimated prevalence of approximately 30%. Toxoplasmosis is a severe disease in the immunocompromised, but few symptoms are exhibited by patients with an intact immune system, making this parasite a worldwide burden. Currently, few drugs exist in treating acute toxoplasmosis and no drugs exist to eliminate the bradyzoite of T. gondii. Effective therapies against acute and chronic toxoplasmosis are urgently needed to reduce the burden of this disease. This review aims to give a summary of recent findings in the bradyzoite form of Toxoplasma gondii and the implication of these findings on drug development. A thorough search of PubMed and Google Scholar databases was used to identify studies within the past 10 years that illustrate targetable key elements in the differentiation and formation of the bradyzoite form of T. gondii.